We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+16.73%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$7.31B
AUM Growth
+$1.27B
Cap. Flow
+$483M
Cap. Flow %
6.6%
Top 10 Hldgs %
32.03%
Holding
355
New
109
Increased
77
Reduced
150
Closed
13

Top Buys

Rank Stock Value
1
DDOG icon
Datadog
DDOG
+$69.4M
2
RBLX icon
Roblox
RBLX
+$67M
3
ADBE icon
Adobe
ADBE
+$48.4M
4
ANET icon
Arista Networks
ANET
+$47.4M
5
EPAM icon
EPAM Systems
EPAM
+$29M

Top Sells

Rank Stock Value
1
RGEN icon
Repligen
RGEN
+$30M
2
MBLY icon
Mobileye
MBLY
+$26.6M
3
CALX icon
Calix
CALX
+$15.7M
4
HUBS icon
HubSpot
HUBS
+$15.7M
5
DEN
Denbury Inc.
DEN
+$15.7M

Sector Composition

Rank Sector Weight
1 Technology 32.88%
2 Consumer Discretionary 19.89%
3 Healthcare 16.44%
4 Communication Services 10%
5 Industrials 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FINW icon
176
FinWise Bancorp
FINW
$178M
$2.35M 0.03%
262,309
-18,404
-7% -$156K
RLAY icon
177
Relay Therapeutics
RLAY
$4.18B
$2.34M 0.03%
186,102
+83,502
+81% +$1.04M
IRTC icon
178
iRhythm Holdings
IRTC
$3.71B
$2.29M 0.03%
21,984
-161
-0.7% -$19.3K
GFS icon
179
GlobalFoundries
GFS
$24.5B
$2.27M 0.03%
35,096
-4
-0% -$242
WFC icon
180
Wells Fargo
WFC
$267B
$2.23M 0.03%
52,330
– –
KYMR icon
181
Kymera Therapeutics
KYMR
$9.56B
$2.04M 0.03%
88,732
-764
-0.9% -$21.9K
SHW icon
182
Sherwin-Williams
SHW
$78.9B
$1.92M 0.03%
7,224
+1,254
+21% +$295K
SRPT icon
183
Sarepta Therapeutics
SRPT
$2.17B
$1.87M 0.03%
16,360
-414
-2% -$53.4K
SLB icon
184
SLB Ltd
SLB
$79.5B
$1.78M 0.02%
36,338
-381
-1% -$18.2K
KRTX
185
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.71M 0.02%
7,892
+552
+8% +$118K
BABA icon
186
Alibaba
BABA
$268B
$1.65M 0.02%
19,772
-39
-0.2% -$3.41K
IAUX
187
i-80 Gold Corp
IAUX
$1.49B
$1.62M 0.02%
720,365
-5,407
-0.7% -$12.7K
HIMS icon
188
Hims & Hers Health
HIMS
$6.46B
$1.6M 0.02%
170,074
+84,388
+98% +$837K
CROX icon
189
Crocs
CROX
$5.39B
$1.6M 0.02%
14,215
+867
+6% +$103K
ATVI
190
DELISTED
Activision Blizzard
ATVI
$1.59M 0.02%
18,914
-255
-1% -$20.6K
ETNB
191
DELISTED
89bio
ETNB
$1.53M 0.02%
80,963
+4,960
+7% +$87.1K
BWIN
192
Baldwin Insurance Group
BWIN
$3.11B
$1.53M 0.02%
61,850
-22,289
-26% -$528K
BLZE icon
193
Backblaze
BLZE
$813M
$1.53M 0.02%
352,707
-43,057
-11% -$185K
CMG icon
194
Chipotle Mexican Grill
CMG
$43.4B
$1.5M 0.02%
35,050
– –
BRK.B icon
195
Berkshire Hathaway Class B
BRK.B
$1.11T
$1.47M 0.02%
4,311
-148
-3% -$48.3K
RVNC
196
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.45M 0.02%
57,123
+1,606
+3% +$50K
EWCZ
197
DELISTED
European Wax Center
EWCZ
$1.44M 0.02%
77,279
+41,916
+119% +$750K
PEN icon
198
Penumbra
PEN
$12.6B
$1.42M 0.02%
4,138
-270
-6% -$82.9K
TXG icon
199
10x Genomics
TXG
$9.99B
$1.41M 0.02%
25,276
+9,566
+61% +$518K
AIRS icon
200
AirSculpt Technologies
AIRS
$152M
$1.38M 0.02%
159,595
+12,692
+9% +$83K
6 7
8
9 10

Similar funds

Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
SC
Starlite Capital Dallas, Texas $9.7B AUM
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.8B AUM 0.07% 1-Year Est. Return
HTC
Hershey Trust Company Hershey, Pennsylvania $9.82B AUM 0.48% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Gilder Gagnon Howe & Co held 355 positions worth $7.31B, up 21% from $6.04B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Gilder Gagnon Howe & Co deployed $483M of net new capital in Q2 2023, opening 109 new positions and adding to 77 existing holdings. Its largest new stake was Intel: 532,525 shares worth $17.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Repligen, an estimated $30M trimmed.

  • Gilder Gagnon Howe & Co's largest Q2 2023 buy was Intel: 532,525 shares worth $17.8M.
  • Gilder Gagnon Howe & Co added most to Datadog in Q2 2023, an estimated $69.4M increase.
  • Gilder Gagnon Howe & Co's biggest Q2 2023 reduction was Repligen, cutting an estimated $30M.
  • Gilder Gagnon Howe & Co fully exited Apollo Endosurgery, Inc. in Q2 2023, selling an estimated $3.69M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 32% of its $7.31B portfolio in Q2 2023.
  • Gilder Gagnon Howe & Co opened 109 new positions and closed 13 in Q2 2023.
  • Gilder Gagnon Howe & Co's portfolio value rose 21% quarter-over-quarter to $7.31B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2023, filed 14 Aug 2023.